Save your place

Sign in to WhoBought

Please try again later.

Palvella Therapeutics, Inc. (PVLA) institutional ownership

Latest close $150.19 Jul 30, 2026
Market cap$1.6B 52-week range SectorHealthcare
Funds holding · Q1 2026
174
reported PVLA position changes
Top owners · Q2 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
124 buyers · 50 sellers

Palvella Therapeutics, Inc. (PVLA) price and institutional activity

Dates

Q1 2026

$0 bought by 124 investors
T. Rowe Price AssociatesFirst Light Asset Management, LLC +122 more
$0 sold by 50 investors
Summit Partners Public Asset Management, LLCPerceptive Advisors LLC +48 more
Bought Sold Totals per quarter; hover a bar for the names.

Palvella Therapeutics, Inc. (PVLA) institutional activity · 50

Investor Type Est. change Change Δ Own Date
Summit Partners Public Asset Management, LLC · Exited
Change −389K Δ Own −100.0% Date Q1 2026
Summit Partners Public Asset Management, LLC Exited· Q1 2026 −389K −100.0% Q1 2026
Perceptive Advisors LLC · Exited
Change −266K Δ Own −100.0% Date Q1 2026
Perceptive Advisors LLC Exited· Q1 2026 −266K −100.0% Q1 2026
Fred Alger Management, LLC · Reduced
Change −129K Date Q1 2026
Fred Alger Management, LLC Reduced· Q1 2026 −129K Q1 2026
Morgan Stanley · Reduced
Change −93K Date Q1 2026
Morgan Stanley Reduced· Q1 2026 −93K Q1 2026
Samsara Biocapital, LLC · Reduced
Change −66K Date Q1 2026
Samsara Biocapital, LLC Reduced· Q1 2026 −66K Q1 2026
Artia Global Partners LP · Exited
Change −59K Δ Own −100.0% Date Q1 2026
Artia Global Partners LP Exited· Q1 2026 −59K −100.0% Q1 2026
Superstring Capital Management LP · Exited
Change −25K Δ Own −100.0% Date Q1 2026
Superstring Capital Management LP Exited· Q1 2026 −25K −100.0% Q1 2026
Barclays PLC · Reduced
Change −23K Date Q1 2026
Barclays PLC Reduced· Q1 2026 −23K Q1 2026
Artisan Partners Limited Partnership · Reduced
Change −18K Date Q1 2026
Artisan Partners Limited Partnership Reduced· Q1 2026 −18K Q1 2026
FMR LLC · Reduced
Change −16K Δ Own −6.9% Date Q1 2026
FMR LLC Reduced· Q1 2026 −16K −6.9% Q1 2026
Balyasny Asset Management L.P. · Reduced
Change −12K Date Q1 2026
Balyasny Asset Management L.P. Reduced· Q1 2026 −12K Q1 2026
Verition Fund Management LLC · Exited
Change −12K Δ Own −100.0% Date Q1 2026
Verition Fund Management LLC Exited· Q1 2026 −12K −100.0% Q1 2026
Catalio Capital Management, LP · Exited
Change −10K Δ Own −100.0% Date Q1 2026
Catalio Capital Management, LP Exited· Q1 2026 −10K −100.0% Q1 2026
Marshall Wace, LLP · Exited
Change −9K Δ Own −100.0% Date Q1 2026
Marshall Wace, LLP Exited· Q1 2026 −9K −100.0% Q1 2026
Blue Owl Capital Holdings LP · Reduced
Change −9K Date Q1 2026
Blue Owl Capital Holdings LP Reduced· Q1 2026 −9K Q1 2026
Data through Q1 2026 · filed May 28, 2026
15 of 50

Famous investor activity in Palvella Therapeutics, Inc. (PVLA)

Palvella Therapeutics, Inc. (PVLA) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Goin Kathleen · Officer 4 operations −$642K
Price $147.14–$150.25 Qty −4K Owned 0 ΔOwn −100.0% Trade date Jul 15, 2026 Filed date Jul 17, 2026
Goin Kathleen Officer 4 operations $147.14–$150.25 −4K −$642K 0 −100.0% Jul 15, 2026 Jul 17, 2026
Goin Kathleen · Officer 4 operations 0
Price $7.14–$9.08 Owned 6K Trade date Jul 15, 2026 Filed date Jul 17, 2026
Goin Kathleen Officer 4 operations $7.14–$9.08 0 6K Jul 15, 2026 Jul 17, 2026
Pauls Matthew · Director Grant (A) 6K
Owned 6K Trade date Jun 29, 2026 Filed date Jul 1, 2026
Pauls Matthew Director Grant (A) 6K 6K Jun 29, 2026 Jul 1, 2026
Goin Kathleen · Officer 3 operations −$476K
Price $110.26–$112.23 Qty −4K Owned 0 ΔOwn −100.0% Trade date Jun 17, 2026 Filed date Jun 22, 2026
Goin Kathleen Officer 3 operations $110.26–$112.23 −4K −$476K 0 −100.0% Jun 17, 2026 Jun 22, 2026
Goin Kathleen · Officer 4 operations 0
Price $7.14–$9.08 Owned 9K Trade date Jun 17, 2026 Filed date Jun 22, 2026
Goin Kathleen Officer 4 operations $7.14–$9.08 0 9K Jun 17, 2026 Jun 22, 2026
Korenberg Matthew E. · Officer 2 operations 0
Price $13.60 Owned 166K Trade date Jun 12, 2026 Filed date Jun 16, 2026
Korenberg Matthew E. Officer 2 operations $13.60 0 166K Jun 12, 2026 Jun 16, 2026
Kiritsy Christopher P. · Director Grant (A) 3K
Owned 3K Trade date Jun 10, 2026 Filed date Jun 12, 2026
Kiritsy Christopher P. Director Grant (A) 3K 3K Jun 10, 2026 Jun 12, 2026
Jenkins George M. · Director Grant (A) 3K
Owned 3K Trade date Jun 10, 2026 Filed date Jun 12, 2026
Jenkins George M. Director Grant (A) 3K 3K Jun 10, 2026 Jun 12, 2026
Heron Elaine J. · Director Grant (A) 3K
Owned 3K Trade date Jun 10, 2026 Filed date Jun 12, 2026
Heron Elaine J. Director Grant (A) 3K 3K Jun 10, 2026 Jun 12, 2026
Doux John · Director Grant (A) 3K
Owned 3K Trade date Jun 10, 2026 Filed date Jun 12, 2026
Doux John Director Grant (A) 3K 3K Jun 10, 2026 Jun 12, 2026
Davis Todd C. · Director Grant (A) 3K
Owned 3K Trade date Jun 10, 2026 Filed date Jun 12, 2026
Davis Todd C. Director Grant (A) 3K 3K Jun 10, 2026 Jun 12, 2026
Wessel Tadd S. · Director Grant (A) 3K
Owned 3K Trade date Jun 10, 2026 Filed date Jun 12, 2026
Wessel Tadd S. Director Grant (A) 3K 3K Jun 10, 2026 Jun 12, 2026
Goin Kathleen · Officer 3 operations −$476K
Price $110.35–$111.89 Qty −4K Owned 0 Trade date May 20, 2026 Filed date May 22, 2026
Goin Kathleen Officer 3 operations $110.35–$111.89 −4K −$476K 0 May 20, 2026 May 22, 2026
Goin Kathleen · Officer 4 operations 0
Price $7.14–$9.08 Owned 11K Trade date May 20, 2026 Filed date May 22, 2026
Goin Kathleen Officer 4 operations $7.14–$9.08 0 11K May 20, 2026 May 22, 2026
Goin Kathleen · Officer 5 operations −$547K
Price $125.96–$130.33 Qty −4K Owned 0 Trade date Apr 15, 2026 Filed date Apr 17, 2026
Goin Kathleen Officer 5 operations $125.96–$130.33 −4K −$547K 0 Apr 15, 2026 Apr 17, 2026
15 of 35
15 of 35 Sign in to continue to older insider transactions.

Palvella Therapeutics, Inc. (PVLA) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Blackrock, Inc. 813K
% of shares outstanding 5.7% Filing date Jul 29, 2026
Blackrock, Inc. 813K 5.7% Jul 29, 2026
Soleus Capital Master Fund, L.P. 3.9M
% of shares outstanding 5.4% Filing date Jan 27, 2022
Soleus Capital Master Fund, L.P. 3.9M 5.4% Jan 27, 2022
Aquilo Capital Management, LLC 3.8M
% of shares outstanding 5.2% Filing date Feb 14, 2022
Aquilo Capital Management, LLC 3.8M 5.2% Feb 14, 2022
Seagen Inc. 3.7M
% of shares outstanding 5.0% Filing date Feb 10, 2023
Seagen Inc. 3.7M 5.0% Feb 10, 2023
Nussbaum Ran 35.7M
% of shares outstanding 5.0% Filing date Feb 14, 2022
Nussbaum Ran 35.7M 5.0% Feb 14, 2022
Frazier Life Sciences Public Fund, L.P. 526K
% of shares outstanding 4.8% Filing date May 15, 2025
Frazier Life Sciences Public Fund, L.P. 526K 4.8% May 15, 2025
Astrazeneca PLC 3.6M
% of shares outstanding 4.8% Filing date Feb 10, 2023
Astrazeneca PLC 3.6M 4.8% Feb 10, 2023
Citadel Advisors LLC 3.2M
% of shares outstanding 4.4% Filing date Feb 14, 2022
Citadel Advisors LLC 3.2M 4.4% Feb 14, 2022
8 of 9

Palvella Therapeutics, Inc. (PVLA) ownership FAQ

Who owns PVLA?

174 reporting institutions disclosed PVLA position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.